Junfei Jin
Impact in
-
- Sphingolipid Metabolism and Signaling
- Lipid Membrane Structure and Behavior
- Metabolism, Diabetes, and Cancer
- Extracellular vesicles in disease
-
- MicroRNA in disease regulation
Papers in
-
- Sphingolipid Metabolism and Signaling 9
- Metabolism, Diabetes, and Cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
- Extracellular vesicles in disease 2
- Surgery 4
- Organ Transplantation Techniques and Outcomes 2
- Co-authors
- Juan Xiao (4 shared papers)Jacek Bielawski (2 shared papers)Thomas D. Mullen (2 shared papers)Yi‐Te Hsu (2 shared papers)Yusuf A. Hannun (2 shared papers)Alicja Bielawska (2 shared papers)Lina M. Obeid (2 shared papers)Mingjun Dong (3 shared papers)
- Journals
- BMC Genomics (2 papers)Cell Death and Disease (2 papers)Journal of Lipid Research (1 paper)Frontiers in Pharmacology (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Junfei Jin
20 papers receiving 475 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 305
- Cancer Research 58
- Cell Biology 62
- Immunology 67
- Biochemistry 17
Countries citing papers authored by Junfei Jin
This map shows the geographic impact of Junfei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfei Jin more than expected).
Fields of papers citing papers by Junfei Jin
This network shows the impact of papers produced by Junfei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfei Jin. The network helps show where Junfei Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 94 | |
| 2 | 2008 | 70 | |
| 3 | 2019 | 51 | |
| 4 | 2018 | 39 | |
| 5 | 2022 | 32 | |
| 6 | 2017 | 31 | |
| 7 | 2012 | 28 | |
| 8 | 2018 | 26 | |
| 9 | 2020 | 24 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2019 | 16 | |
| 13 | 2020 | 9 | |
| 14 | 2017 | 7 | |
| 15 | Serum sphingosine 1-phosphate in hepatocellular carcinoma patients is related to HBV infection. | 2019 | 6 |
| 16 | 2022 | 5 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2019 | 1 | |
| 20 | 2024 | 1 |
About Junfei Jin
Junfei Jin is a scholar working on Molecular Biology, Surgery, Epidemiology, Transplantation and Cell Biology, having authored 22 papers that have together received 481 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (9 papers), Liver Disease and Transplantation (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Extracellular vesicles in disease (2 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Molecular Biology (305 citations), Cancer Research (58 citations), Cell Biology (62 citations), Immunology (67 citations) and Biochemistry (17 citations). Junfei Jin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Juan Xiao, Jacek Bielawski, Thomas D. Mullen, Yi‐Te Hsu, Yusuf A. Hannun, Alicja Bielawska, Lina M. Obeid, Mingjun Dong, Qi Hou and Xiaoming Zhang. Their work appears in journals such as BMC Genomics, Cell Death and Disease, Journal of Lipid Research, Frontiers in Pharmacology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.